Tokyo, Japan

Sonoko Atsumi


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):

Title: Sonoko Atsumi: Pioneering Cancer Research

Introduction

Sonoko Atsumi, based in Tokyo, Japan, is a notable inventor with a significant contribution to the field of cancer research. Her work has led to the development of innovative solutions aimed at inhibiting the growth of cancer cells. With one patent to her name, Sonoko has demonstrated her commitment to advancing medical science and improving treatment options for cancer patients.

Latest Patents

Sonoko Atsumi holds a patent for a cancer cell growth inhibitor, which includes an anticancer agent and a novel screening method. This patent encompasses a unique compound that is a cancer cell proliferation inhibitor. The compound is distinguished by its effectiveness against cancer cells that overexpress the wild-type epidermal growth factor receptor and those expressing the mutant variant, vIII. This innovative approach offers potential pathways for the creation of targeted cancer therapies.

Career Highlights

Throughout her career, Sonoko has made significant strides in cancer research. She has been associated with the Microbial Chemistry Research Foundation and Gakubunkan, where she has honed her skills and contributed meaningfully to ongoing projects in the realm of cancer treatments. Her dedication to research is evident in her persistent quest for innovative solutions to complex medical challenges.

Collaborations

In her professional journey, Sonoko has worked alongside esteemed colleagues, including Masabumi Shibuya and Shun-ichi Ohba. These collaborations have enriched her work, allowing for a blend of experiences and ideas that have propelled her research forward. The synergy between Sonoko and her colleagues exemplifies the importance of teamwork in scientific breakthroughs.

Conclusion

Sonoko Atsumi stands as a testament to the impact of dedicated research in the fight against cancer. Her patent for a cancer cell growth inhibitor highlights her innovative spirit and commitment to improving patient outcomes. As she continues her work in this essential field, her contributions remain vital in the ongoing pursuit of effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…